Growth stocks have recently attracted investor interest. The Russell 3000 Growth Index returned 39.8% over the last year ...

Nuvie Bio, a new clinical-stage biopharmaceutical company dedicated to addressing the most pressing unmet medical needs in migraine and related neurological diseases, announced completion of a ...

Series Novel Combinations (Dopamine Pathway) is under clinical development by Alto Neuroscience and currently in Phase I for Unspecified Psychiatric Disorders.

Iluzanebart is under clinical development by Vigil Neuroscience and currently in Phase I for Unspecified Neurologic Disorders.

Patient Enrollment Ongoing in Phase 2 RECONNECT Trial of RE104 in Postpartum Depression (PPD); Topline Data Anticipated Mid-2025Initiation of ...

Deep sleep may clear the brain of toxic waste via a process driven by norepinephrine, a molecule that creates rhythmic blood vessel contractions.

Ex-pizzaman who rescued 4 kids from house fire reacts to Donald Trump Jr, Musk calling for him to receive Medal of Freedom Scientists reveal dopamine and serotonin’s opposing roles in fascinating ...

Myristamide enhances cognitive function and BDNF in mice, indicating Camembert cheese's potential in combating cognitive ...

Joe Scarborough blames 'slashed' infrastructure spending for failing to protect LA residents Maddow Blog | Trump sentenced to unconditional discharge in New York hush money case Mel Gibson's house ...

Medtronic offers solid income potential with a 3.5% dividend yield. Read why MDT stock’s forward P/E ratio signals possible ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company focused on marketed products and development candidates, announced its participat ...